Labshake search
Citations for Tocris :
301 - 350 of 552 citations for 7 Benzyloxy 1H indazole 3 carboxylic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... Animals first received 10 mg/kg of kainic acid (Tocris Bioscience, UK) mixed in 1x PBS (8 ml per 10 mg ...
-
bioRxiv - Neuroscience 2020Quote: ... animals were exposed to 10mM 6-OHDA/2mM ascorbic acid (Tocris Bioscience) for one-hour at 20°C ...
-
bioRxiv - Neuroscience 2022Quote: ... D-2-Amino-5-phosphonopentanoic acid (D-AP5, 25 μM; Tocris #0106). These were stored as stock aliquots and diluted in fresh aCSF to their final concentration the day of recording ...
-
bioRxiv - Neuroscience 2022Quote: ... 20 μM CNQX and 5 μM 5,7-DiCl-kynurenic acid (Tocris, UK). For whole-cell GABAR-mediated currents ...
-
bioRxiv - Neuroscience 2023Quote: ... 1 μM retinoic acid (STEMCELL) and 500 mg/ml cyclic AMP (Tocris), with medium changes three times a week.
-
bioRxiv - Cell Biology 2023Quote: ... 10 ng/ml BMP4 and 50 nM all-trans Retinoic acid (Tocris)) for 48 hours and three-dimensional clump formation was observed ...
-
Autism genes converge on microtubule biology and RNA-binding proteins during excitatory neurogenesisbioRxiv - Systems Biology 2024Quote: ... 0.2mM ascorbic acid) containing small molecules 1uM PD0325901 (P)(Tocris, Cat#4192), 5uM SU5402 (SU)(MilliporeSigma ...
-
bioRxiv - Developmental Biology 2021Quote: ... Cells were then differentiated for 3 days (D) in N2B27 supplemented with 3 µM Chiron99021 (Tocris, Cat. No. 4953) and 20ng/ml bFGF (PeproTech ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 μM of 2,3-dihydroxy 6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX, 1044, Tocris Bioscience, UK), 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Cancer Biology 2022Quote: Pancreatitis was induced by 7 intraperitoneal injections of cerulein (50 μg/kg; Tocris Bioscience, cat#62-641) at hourly intervals on two alternating days ...
-
bioRxiv - Neuroscience 2019Quote: ... Cells were split 12–30 h after transfection and plated on glass coverslips in the presence of 50 μM NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; Tocris Bioscience) to avoid AMPAR-mediated toxicity ...
-
bioRxiv - Neuroscience 2021Quote: ... SR95531 (gabazine) and 4-methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-caged glutamate) were purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2024Quote: ... All networks received a 20-min 50 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, in DMSO; Tocris, #0373) treatment on top of that ...
-
bioRxiv - Neuroscience 2024Quote: ... IPSCs were recorded in the presence of 10µM CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Tocris 1045) and 50µM D-AP5 (D-2-amino-5-phosphonovalerate ...
-
bioRxiv - Neuroscience 2021Quote: ... mEPSCs were recorded in aCSF supplemented with 10 μM N-[3-[4-(3-Aminopropylamino)butylamino]propyl]-2-naphthalen-1-ylacetamide trihydrochloride (NASPM, Tocris) to selectively block CP-AMPARs ...
-
bioRxiv - Cell Biology 2020Quote: ... 3 µM CHIR99021 (Tocris 4423, or Axon 1386); 4 µM TCS JNK 60 (Tocris 3222) ...
-
bioRxiv - Neuroscience 2019Quote: ... 3-dione (CNQX, Tocris, 50 μM final concentration). CNQX and DQNX were assumed to act equally ...
-
bioRxiv - Neuroscience 2020Quote: ... In all cases 3 mg/ml biocytin (Tocris) was added in the recording solution and no extra pharmacology was added ...
-
bioRxiv - Cell Biology 2021Quote: ... p38 MAPK inhibitor SB203580 (3 uM, Tocris, #1202), JNK inhibitor SP600125 (20uM ...
-
bioRxiv - Neuroscience 2022Quote: ... GABA (500 µL, 3 mM, Tocris Bioscience, 0344), CaCl2 (370 µL ...
-
bioRxiv - Bioengineering 2022Quote: ... 3 μM CHIR99021 (Tocris Bioscience, catalogue no. 4423), 50 nM PI-103 (Tocris Bioscience ...
-
bioRxiv - Developmental Biology 2021Quote: ... 3 mM GSK3 inhibitor CHIR99021 (4953/50 Tocris), and 1,000 U/ml LIF (ESGRO ESG1107 ...
-
bioRxiv - Neuroscience 2021Quote: ... In some cases 3 mg/ml biocytin (Tocris) was added in the recording solution ...
-
bioRxiv - Neuroscience 2022Quote: ... 3) a selective PIEZO1 agonist Yoda1 (5586, Tocris). For pressure pulse stimulation ...
-
bioRxiv - Developmental Biology 2023Quote: ... N2B27 was supplemented with 3 µM CHIR99021 (Tocris), 1 µM PD0325901 (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... 3 mM L-glutamate (Glu, #0218, Tocris, UK) and 0.1 mM cyclothiazide (CTZ ...
-
bioRxiv - Bioengineering 2023Quote: ... which included 3 µM CHIR 99021 (Tocris, 4423) +/- 10 µM Y27632 (StemCell Technologies ...
-
bioRxiv - Neuroscience 2019Quote: ... and 50 μM D,L-2-amino-5-phosphonovaleric acid / AP5 (Tocris Bioscience). Coverslips were mounted in an RC-21BRFS chamber (Warner Instruments ...
-
bioRxiv - Neuroscience 2019Quote: ... and 50 µM D-2-amino-5-phosphonovaleric acid (D-AP-5; Tocris) to isolate synaptic inhibitory transmission ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs were first treated with the sialic acid inhibitor P-3FAX-Neu5Ac (Tocris) for 24 hours ...
-
bioRxiv - Neuroscience 2019Quote: ... at concentrations of 34 μM and 340 μM and dihydrokainic acid (DHK) (Tocris), an excitatory amino acid 2 (EAAT2 ...
-
bioRxiv - Microbiology 2021Quote: ... 1 mM orange-red TAMRA-based fluorescent D-amino acid (RADA, Tocris, 6649) was added to the µ-dish ...
-
bioRxiv - Neuroscience 2023Quote: ... and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV, Tocris, 0106) to block glutamatergic inputs ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX and D(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) were from Tocris Biosciences ...
-
bioRxiv - Neuroscience 2023Quote: ... (S)-2-Amino-2-methyl-4-phosphonobutanoic acid (MAP4; 250 µM; Tocris, Item# 0711), Tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2023Quote: ... DL-2- amino-5-phosphono-pentanoic acid (AP5; 50 µM; Tocris, Item# 0105), 4-Aminopyridine (4- AP ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDAR antagonist D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50µM, Tocris-0106) and tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2024Quote: ... or kainic acid (1mg/ml dissolved in sterile saline, Tocris; Catalog No: 0222), were injected into the lateral habenula ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Cell Biology 2021Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt (NBQX; #1044) and Kainate (KA; #0222) were purchased from Tocris. L-Glutamic acid monosodium salt (Glu ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.
-
bioRxiv - Neuroscience 2020Quote: ... (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-5-phenylthiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione (ACET; 1μM; Tocris Bioscience, catalog #2728).
-
bioRxiv - Microbiology 2024Quote: To investigate the impact of gallein (3’,4’,5’,6’-Tetrahydroxyspiro[isobenzofuran-1(3H),9’- (9H)xanthen]-3-one) (Cat#3090, Tocris, Minneapolis, MN) and/or INH on Mtb growth ...
-
bioRxiv - Cell Biology 2021Quote: ... or the AMPA-iGluR specific inhibitor 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, cat. num. 373, Tocris). Drugs were dissolved in ESC complete media (no 2i ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Cell Biology 2022Quote: To observe chromosome alignment in fixed-cell experiments – with the advantage of taking high resolution images and easily selecting many cells for further analysis - cells were released from thymidine block for 7 hours before being treated for 2 hours with RO-3306 (10μM, Tocris) – to synchronise cells at the G2/M boundary - or with a 3-hour treatment with STLC (10μM ...
-
bioRxiv - Neuroscience 2019Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (“NBQX”, 100 mM in DMSO, Tocris Cat No 0373); D-2-amino-5-phosphonovalerate (“D-AP5” ...
-
bioRxiv - Cell Biology 2019Quote: ... HeLa FRT cells were released from thymidine block (40 h after siRNA treatment) for 7 hours before arresting at the G2/M boundary with RO-3306 treatment (10μM, Tocris) for 2 hours ...